{"id":"W4405012333","doi":"10.1136/jitc-2024-010094","title":"Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial","year":2024,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Alberta Cancer Foundation; Centre Hospitalier de l’Université de Montréal; Hôpital du Sacré-Cœur de Montréal; Moncton Hospital; Trillium Health Centre; Juravinski Cancer Centre; Ottawa Hospital; Saskatchewan Cancer Agency; St. John’s Health Sciences Centre; Hôpital Charles-Le Moyne; Hôtel-Dieu de Québec; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"Eisai; Taiho Pharmaceutical; Natera; Exelixis; AstraZeneca; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Colorectal cancer; Internal medicine; Oncology; Immune system; Hazard ratio; Biomarker; Cancer; Gastroenterology; Immunology; Biology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003196758,0.0001570815,0.0004233106,0.00021837,0.00007260804,0.00002631752,0.00009806005,0.0000591188,0.00007252817],"category_scores_gemma":[0.00004469144,0.0000931172,0.0005577454,0.0004123199,0.0001393487,0.00001462105,0.00001530668,0.0001167827,1.578365e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001778173,"about_ca_system_score_gemma":0.0006689714,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000867106,"about_ca_topic_score_gemma":0.002029213,"domain_scores_codex":[0.9988526,0.00006559386,0.000443517,0.0001926026,0.0002400391,0.0002056894],"domain_scores_gemma":[0.9992317,0.00009804807,0.0003144559,0.00012033,0.0002003728,0.00003507267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.3648751,0.0006197505,0.01395911,0.0001442853,0.04457666,0.000008642225,0.00134655,0.00328939,0.5544624,0.00004341371,0.0004804007,0.01619433],"study_design_scores_gemma":[0.0862574,0.01037851,0.04550799,0.0005153081,0.00215133,0.00002300097,0.0004152942,0.004649057,0.8446087,0.000354732,0.004839189,0.0002995349],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873748,0.008735709,0.0009315627,0.0003458465,0.0003033549,0.001336059,0.0009417832,0.000003630146,0.0000272589],"genre_scores_gemma":[0.9963588,0.002090486,0.0001124515,0.0000219678,0.00005206318,0.0009167272,0.00004825873,0.0000307768,0.0003684386],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2901463,"threshold_uncertainty_score":0.3797209,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01831053926871016,"score_gpt":0.3701782868469034,"score_spread":0.3518677475781932,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}